Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
Jul 17, 2007

Affymetrix and Children’s Research Institute Ally for Diagnostic Development

  • Affymetrix and Children’s Research Institute inked a deal to leverage arrays to make molecular diagnostic tests better, faster, and more economical.

    The five-year agreement, will allow Children’s Research Institute to build processing capacity to analyze up to 25,000 samples using several Affymetrix arrays. The large-scale clinical studies are designed to enable researchers to better identify the genetic variations associated with common, complex diseases that affect children. The resulting information will be used to develop diagnostic and screening tests.



Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »